Publications
Found 8 results
Filters: Author is Pays, Etienne [Clear All Filters]
"Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host.",
Science, vol. 337, issue 6093, pp. 463-6, 2012 Jul 27.
"High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.",
PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
"[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].",
Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.",
Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
"P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis.",
J Infect Dis, vol. 189, issue 3, pp. 527-39, 2004 Feb 1.
"Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense.",
Am J Trop Med Hyg, vol. 67, issue 3, pp. 289-95, 2002 Sep.
"Selective pressure can influence the resistance of Trypanosoma congolense to normal human serum.",
Exp Parasitol, vol. 102, issue 2, pp. 61-5, 2002 Oct.
"The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense.",
Am J Trop Med Hyg, vol. 67, issue 6, pp. 684-90, 2002 Dec.